Michael Novod

Michael Novod is the head of equity research for Denmark at Nordea Bank, where he provides insights into financial markets and investment strategies, particularly in the pharmaceutical sector. Recently, he commented on Novo Nordisk's restructuring efforts under new CEO Mike Doustdar, indicating that the changes aim to simplify operations and redirect resources toward growth.